United States was Synergy CHC’s largest region in fiscal 2025, bringing in $27.32M of $30.38M (90%).
| Geography | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2023 | FY 2025 |
|---|---|---|---|---|---|---|---|---|
| United States | $40.62M | $27.32M | ||||||
| U.S | — | — | ||||||
| Canada | — | $2.42M | ||||||
| Foreign Countries | $2.16M | — | ||||||
| Mexico | — | $623.66K | ||||||
| Other | — | $20.72K | ||||||
| Total | $42.78M | $30.38M |
Synergy CHC brought in $30.38M from its four regions in fiscal 2025, the year ended December 31, 2025. Synergy CHC regrouped these regions after fiscal 2023, so the total does not compare directly with that year's $42.78M. United States was the largest at $27.32M (89.9%), ahead of Canada at $2.42M (8.0%) and Mexico at $623.66K (2.1%). The remaining region, Other, brought in $20.72K.
Synergy CHC began breaking out Canada in fiscal 2025, Mexico in fiscal 2025 and Other in fiscal 2025. Synergy CHC stopped reporting Foreign Countries as a separate region after fiscal 2023, when it brought in $2.16M.
Nutraceuticals was Synergy CHC’s largest segment in fiscal 2025, bringing in $29.73M of $30.38M (98%).
| Segment | FY 2018 | FY 2019 | FY 2023 | FY 2025 |
|---|---|---|---|---|
| Nutraceuticals | $42.75M | $29.73M | ||
| Cosmeceuticals | — | — | ||
| Beverages | — | $631.33K | ||
| Consumer Goods | $24.58K | $17.99K | ||
| Over The Counter (Otc) | — | — | ||
| Total | $42.78M | $30.38M |
Synergy CHC brought in $30.38M from its three segments in fiscal 2025, the year ended December 31, 2025. Synergy CHC regrouped these segments after fiscal 2023, so the total does not compare directly with that year's $42.78M. Nutraceuticals was the largest at $29.73M (97.9%), ahead of Beverages at $631.33K (2.1%) and Consumer Goods at $17.99K (0.1%).
Synergy CHC began breaking out Beverages in fiscal 2025, when it brought in $631.33K.
Retail was Synergy CHC’s largest product and service line in fiscal 2025, bringing in $22.25M of $30.38M (73%).
| Product and Service | FY 2018 | FY 2019 | FY 2023 | FY 2025 | FY 2025 | FY 2025 |
|---|---|---|---|---|---|---|
| Retail | $31.78M | — | — | $22.25M | ||
| Online | $11.00M | — | — | $8.13M | ||
| License Revenue | — | $500.00K | $900.00K | — | ||
| Total | $42.78M | $500.00K | $900.00K | $30.38M |
Synergy CHC brought in $30.38M from its two product and service lines in fiscal 2025, the year ended December 31, 2025. Synergy CHC regrouped these lines after fiscal 2025, so the total does not compare directly with that year's $900.00K. Retail was the largest at $22.25M (73.2%), ahead of Online at $8.13M (26.8%).
From fiscal 2023 to 2025, combined revenue from these lines fell from $42.78M to $30.38M, a compound annual decline of 15.7%. Retail's share of the total fell from 74.3% to 73.2%.
Synergy CHC stopped reporting License Revenue as a separate line after fiscal 2025, when it brought in $900.00K.
Synergy CHC (SNYR) reports its revenue by geography, by segment and by product and service. In fiscal 2025, United States was its largest region, bringing in $27.32M (89.9% of the total), followed by Canada at $2.42M (8.0%).
United States was Synergy CHC's largest region in fiscal 2025, bringing in $27.32M, or 89.9% of the $30.38M total across its four regions.
Nutraceuticals was Synergy CHC's largest segment in fiscal 2025, bringing in $29.73M, or 97.9% of the $30.38M total across its three segments.
Retail was Synergy CHC's largest product and service line in fiscal 2025, bringing in $22.25M, or 73.2% of the $30.38M total across its two product and service lines.
Every figure comes from Synergy CHC's annual financial filings, as reported. Each line keeps the name Synergy CHC gives it, and years follow its fiscal calendar.
Synergy CHC's revenue by geography goes back to fiscal 2014, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.